Clinical Trial Update: Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection [NA]

View source ↗

Summary

A clinical trial update describes a study of sorafenib combined with transarterial chemoembolization (TACE) as adjuvant therapy for hepatocellular carcinoma wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Hepatocellular Carcinoma | NA | Status: UNKNOWN